Otolaryngology Doctors in Lafayette, CO Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

Dr. Andrea E.s. Potash, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Kevin K Motamedi, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Arthur J Dichard, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Kevin Kendall Bach, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Trudi A Woodson, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Gary L Mcdonald, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Charles B Armstrong, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

News Archive

Increase in nurses' workload linked to high mortality risk in patients

Nurses are the front-line caregivers to hospital patients, coordinating and providing direct care and delivering it safely and reliably. The goal for any hospital is to ensure that each of its patient-care units has an adequate number of nurses during every shift.

Viewpoints: Hoping that 'Gang of Six' will cut fiscal deal; Sen. Alexander links health law and college tuition increases

The public has a famously low opinion of Congress, even though people tend to hold a less disparaging view of their own representatives. The last two years have been especially tough on the institution's reputation, a response to the body's relentless brinkmanship and paralyzing partisanship in the face of a slow economy. So it is with some trepidation that I throw out a little love for a handful of senators still seeking bipartisan agreement on a plan to bring the federal government back to fiscal responsibility.

New fluid gels delay release of drugs to benefit young children, others

SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.

AVEO's initiation of SCH 900105 Phase 2 trial in non-small cell lung cancer triggers $8.5M milestone payment

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announces its schedule for filing with the U.S. government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy and RecoveryRx™ products. In these applications BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy product for indications for the treatment of heel and foot pain, and for pain relief relative to general musculoskeletal complaints.

Read more Medical News

› Verified 8 days ago